259 related articles for article (PubMed ID: 37573554)
21. Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients.
Cautilli F; Feleppa M; Valeriani M; Papetti L; Monte G; Midulla F; Spalice A
Front Neurol; 2023; 14():1099458. PubMed ID: 36908623
[TBL] [Abstract][Full Text] [Related]
22. [Encephalitis following COVID-19 disease].
Varannai L; Magyar Z; Baranyai B; Ajzner É; Czurkó M
Ideggyogy Sz; 2021 Jul; 74(7-08):277-285. PubMed ID: 34370409
[TBL] [Abstract][Full Text] [Related]
23. The case of encephalitis in a COVID-19 pediatric patient.
Urso L; Distefano MG; Cambula G; Colomba AI; Nuzzo D; Picone P; Giacomazza D; Sicurella L
Neurol Sci; 2022 Jan; 43(1):105-112. PubMed ID: 34668122
[TBL] [Abstract][Full Text] [Related]
24. Neurological Manifestations in COVID-19 Patients: A Meta-Analysis.
D V; Sharma A; Kumar A; Flora SJS
ACS Chem Neurosci; 2021 Aug; 12(15):2776-2797. PubMed ID: 34260855
[TBL] [Abstract][Full Text] [Related]
25. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies.
Zamani R; Pouremamali R; Rezaei N
Rev Neurosci; 2022 Jun; 33(4):397-412. PubMed ID: 34536341
[TBL] [Abstract][Full Text] [Related]
26. Lethal encephalitis in a pediatric patient with SARS-CoV-2.
Yimenicioğlu S; Zararcı K; Aynacı AM; Yılmaz AT
Turk J Pediatr; 2022; 64(3):571-575. PubMed ID: 35899571
[TBL] [Abstract][Full Text] [Related]
27. Central nervous system reactivation of herpesviridae family in patients with COVID-19.
Haddad M; Sheybani F; Olfati N; Nahayati MA; Boostani R; Layegh P; Rashid-Nejad A
J Neurovirol; 2023 Apr; 29(2):211-217. PubMed ID: 37097596
[TBL] [Abstract][Full Text] [Related]
28. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
[TBL] [Abstract][Full Text] [Related]
29. [Manifestations of the central nervous system after COVID-19].
Gerhard A; Prüß H; Franke C
Nervenarzt; 2022 Aug; 93(8):769-778. PubMed ID: 35552466
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
Romoli M; Jelcic I; Bernard-Valnet R; García Azorín D; Mancinelli L; Akhvlediani T; Monaco S; Taba P; Sellner J;
Eur J Neurol; 2020 Sep; 27(9):1712-1726. PubMed ID: 32503088
[TBL] [Abstract][Full Text] [Related]
31. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
32. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
[TBL] [Abstract][Full Text] [Related]
33. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
34. Neurological consequences of COVID-19.
Brola W; Wilski M
Pharmacol Rep; 2022 Dec; 74(6):1208-1222. PubMed ID: 36180640
[TBL] [Abstract][Full Text] [Related]
35. Neurological associations of COVID-19.
Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
Domingues RB; Leite FBVM; Senne C
Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
[TBL] [Abstract][Full Text] [Related]
37. Neuroimmune disorders in COVID-19.
Ariño H; Heartshorne R; Michael BD; Nicholson TR; Vincent A; Pollak TA; Vogrig A
J Neurol; 2022 Jun; 269(6):2827-2839. PubMed ID: 35353232
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
[TBL] [Abstract][Full Text] [Related]
39. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
40. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry.
Abenza Abildúa MJ; Atienza S; Carvalho Monteiro G; Erro Aguirre ME; Imaz Aguayo L; Freire Álvarez E; García-Azorín D; Gil-Olarte Montesinos I; Lara Lezama LB; Navarro Pérez MP; Pérez Sánchez JR; Romero Delgado F; Serrano Serrano B; Villarreal Vitorica E; Ezpeleta Echávarri D
Neurologia (Engl Ed); 2021 Mar; 36(2):127-134. PubMed ID: 33549369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
